NUVL – nuvalent, inc. - class a (US:NASDAQ)
Stock Stats
News
Nuvalent (NUVL): Assessing an Expensive-Looking Valuation After a Strong Multi-Year Share Price Run [Yahoo! Finance]
Nuvalent to Present at the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
Nuvalent to Present at the 44th Annual J.P. Morgan Healthcare Conference
Nuvalent (NASDAQ:NUVL) had its price target lowered by analysts at JPMorgan Chase & Co. from $147.00 to $145.00. They now have an "overweight" rating on the stock.
Nuvalent (NASDAQ:NUVL) had its "buy" rating reaffirmed by analysts at UBS Group AG.
Form 4 Nuvalent, Inc. For: Dec 22 Filed by: Balcom Alexandra
Form 4 Nuvalent, Inc. For: Dec 22 Filed by: Pelish Henry E.
Form 4 Nuvalent, Inc. For: Dec 19 Filed by: Porter James Richard
Form S-3ASR Nuvalent, Inc.
Form 8-K Nuvalent, Inc. For: Dec 16
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.